Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Li, Zhimei  [Clear All Filters]
Journal Article
Ho SWei Ting, Sheng T, Xing M, Ooi WFong, Xu C, Sundar R, Huang KKyon, Li Z, Kumar V, Ramnarayanan K, et al. Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities. Gut. 2022.
Zhang K, Wang F, Zhao Y, He M, Luo Y, Cheng Y, Luo J, Li Z, Yang J. The regulative effects of levetiracetam on adult hippocampal neurogenesis in mice via Wnt/β-catenin signaling. Neurochem Int. 2019:104643.
Hong JHan, Yong CHan, Heng HLee, Chan JYongsheng, Lau MChan, Chen J, Lee JYi, Lim AHerbert, Li Z, Guan P, et al. Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies. Gut. 2023.
Tan J, Ong CKiat, Lim WKhong, Ng CChuan Youn, Thike AAye, Ng LMoy, Rajasegaran V, Myint SSwe, Nagarajan S, Thangaraju S, et al. Genomic landscapes of breast fibroepithelial tumors. Nat Genet. 2015.
Xing M, Ooi WFong, Tan J, Qamra A, Lee P-H, Li Z, Xu C, Padmanabhan N, Lim JQuan, Guo YAmanda, et al. Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer. J Clin Invest. 2020.
Jiang X, Lim CZi Hui, Li Z, Lee PLeng, Yatim SMaryam JM, Guan P, Li J, Zhou J, Pan J, Chng W-J, et al. Functional Characterization of D9, a Novel Deazaneplanocin A (DZNep) Analog, in Targeting Acute Myeloid Leukemia (AML). PLoS One. 2015;10(4):e0122983.
Fukawa T, Yan-Jiang BChua, Min-Wen JChua, Jun-Hao ETan, Huang D, Qian C-N, Ong P, Li Z, Chen S, Mak SYa, et al. Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia. Nat Med. 2016.
Chen J, Zuo Z, Gao Y, Yao X, Guan P, Wang Y, Li Z, Liu Z, Hong JHan, Deng P, et al. Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide. Clin Epigenetics. 2023;15(1):19.